Alan List

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

The Lancet Oncology · 2009 · 2,176 citations

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

New England Journal of Medicine · 2006 · First of 17 authors · Corresponding · 1,035 citations